SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Unjha Formulations - Quaterly Results

10 May 2023 Evaluate
The sales moved down -33.83% to Rs. 28.42 millions for the March 2023 quarter as compared to Rs. 42.95 millions during the corresponding quarter last year.The Net Loss for the quarter ended March 2023 is Rs. -2.23 millions as compared to Net Loss of Rs. -0.62 millions of corresponding quarter ended March 2022Operating profit Margin for the quarter ended March 2023 slipped to -1.10% as compared to 1.22% of corresponding quarter ended March 2022


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 28.42 42.95 -33.83 131.84 143.51 -8.13 131.84 143.51 -8.13
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDT -1.10 1.22 -190.16 4.63 5.09 -9.04 4.63 5.09 -9.04
Interest 0.47 1.19 -60.50 0.58 1.32 -56.06 0.58 1.32 -56.06
PBDT -1.57 0.03 -5333.33 4.05 3.77 7.43 4.05 3.77 7.43
Depreciation 0.19 0.18 5.56 0.77 0.76 1.32 0.77 0.76 1.32
PBT -1.76 -0.15 1073.33 3.28 3.01 8.97 3.28 3.01 8.97
TAX 0.47 0.47 0.00 0.47 0.47 0.00 0.47 0.47 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -2.23 -0.62 259.68 2.81 2.54 10.63 2.81 2.54 10.63
Equity 44.81 44.81 0.00 44.81 44.81 0.00 44.81 44.81 0.00
PBIDTM(%) -3.87 2.84 -236.26 3.51 3.55 -0.99 3.51 3.55 -0.99

Unjha Formulations Share Price

20.95 -0.05 (-0.24%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×